<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33919537</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>18</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">700</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13040700</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-term care of COVID-19 survivors. It is thus imperative to study post-COVID (i.e., short-term) and long-COVID (i.e., long-term) effects, specifically as local and systemic pathophysiological outcomes of other coronavirus-related diseases (such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS)) were well-cataloged. We conducted a comprehensive review of adverse post-COVID health outcomes and potential long-COVID effects. We observed that such adverse outcomes were not localized. Rather, they affected different human systems, including: (i) immune system (e.g., Guillain-Barr&#xe9; syndrome, rheumatoid arthritis, pediatric inflammatory multisystem syndromes such as Kawasaki disease), (ii) hematological system (vascular hemostasis, blood coagulation), (iii) pulmonary system (respiratory failure, pulmonary thromboembolism, pulmonary embolism, pneumonia, pulmonary vascular damage, pulmonary fibrosis), (iv) cardiovascular system (myocardial hypertrophy, coronary artery atherosclerosis, focal myocardial fibrosis, acute myocardial infarction, cardiac hypertrophy), (v) gastrointestinal, hepatic, and renal systems (diarrhea, nausea/vomiting, abdominal pain, anorexia, acid reflux, gastrointestinal hemorrhage, lack of appetite/constipation), (vi) skeletomuscular system (immune-mediated skin diseases, psoriasis, lupus), (vii) nervous system (loss of taste/smell/hearing, headaches, spasms, convulsions, confusion, visual impairment, nerve pain, dizziness, impaired consciousness, nausea/vomiting, hemiplegia, ataxia, stroke, cerebral hemorrhage), (viii) mental health (stress, depression and anxiety). We additionally hypothesized mechanisms of action by investigating possible molecular mechanisms associated with these disease outcomes/symptoms. Overall, the COVID-19 pathology is still characterized by cytokine storm that results to endothelial inflammation, microvascular thrombosis, and multiple organ failures.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silva Andrade</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8031-9454</Identifier><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Bioinform&#xe1;tica e Qu&#xed;mica Computacional, Departamento de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Estadual do Sudoeste da Bahia (UESB), Jequi&#xe9;, Bahia CEP 45206-190, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>S&#xe9;rgio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Bioinform&#xe1;tica e Qu&#xed;mica Computacional, Departamento de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Estadual do Sudoeste da Bahia (UESB), Jequi&#xe9;, Bahia CEP 45206-190, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Assis Soares</LastName><ForeName>Wagner Rodrigues</ForeName><Initials>WR</Initials><Identifier Source="ORCID">0000-0001-9041-9777</Identifier><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Bioinform&#xe1;tica e Qu&#xed;mica Computacional, Departamento de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Estadual do Sudoeste da Bahia (UESB), Jequi&#xe9;, Bahia CEP 45206-190, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Sa&#xfa;de II, Universidade Estadual do Sudoeste da Bahia (UESB), Jequi&#xe9;, Bahia CEP 45206-190, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza Rangel</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Bioinform&#xe1;tica e Qu&#xed;mica Computacional, Departamento de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Estadual do Sudoeste da Bahia (UESB), Jequi&#xe9;, Bahia CEP 45206-190, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programa de P&#xf3;s-gradua&#xe7;&#xe3;o em Gen&#xe9;tica e Biologia Molecular, Universidade Estadual de Santa Cruz, Ilh&#xe9;us, Bahia CEP 45662-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Naiane Oliveira</ForeName><Initials>NO</Initials><Identifier Source="ORCID">0000-0001-5138-9042</Identifier><AffiliationInfo><Affiliation>Programa de P&#xf3;s-gradua&#xe7;&#xe3;o em Gen&#xe9;tica e Biologia Molecular, Universidade Estadual de Santa Cruz, Ilh&#xe9;us, Bahia CEP 45662-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos Freitas</LastName><ForeName>Andria</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Bioinform&#xe1;tica e Qu&#xed;mica Computacional, Departamento de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Estadual do Sudoeste da Bahia (UESB), Jequi&#xe9;, Bahia CEP 45206-190, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Gen&#xe9;tica Celular e Molecular, Departamento de Biologia Geral, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais CEP 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro da Silveira</LastName><ForeName>Priscila</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Bioinform&#xe1;tica e Qu&#xed;mica Computacional, Departamento de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Estadual do Sudoeste da Bahia (UESB), Jequi&#xe9;, Bahia CEP 45206-190, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiwari</LastName><ForeName>Sandeep</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Gen&#xe9;tica Celular e Molecular, Departamento de Biologia Geral, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais CEP 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzahrani</LastName><ForeName>Khalid J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0002-6688-0106</Identifier><AffiliationInfo><Affiliation>Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;es-Neto</LastName><ForeName>Arist&#xf3;teles</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Biologia Molecular e Computacional de Fungos, Departamento de Microbiologia, Insti-tuto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais CEP 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azevedo</LastName><ForeName>Vasco</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4775-2280</Identifier><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Gen&#xe9;tica Celular e Molecular, Departamento de Biologia Geral, Instituto de Ci&#xea;ncias Biol&#xf3;gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais CEP 31270-901, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Preetam</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-3880-5886</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, Virginia Commonwealth University, Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barh</LastName><ForeName>Debmalya</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2557-7768</Identifier><AffiliationInfo><Affiliation>Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Bio-technology (IIOAB), Nonakuri, Purba Medinipur, West Bengal 721172, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002319" MajorTopicYN="N">Cardiovascular System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003967" MajorTopicYN="N">Diarrhea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="N">Guillain-Barre Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006487" MajorTopicYN="N">Hemostasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007107" MajorTopicYN="N">Immune System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009420" MajorTopicYN="N">Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">adverse effects</Keyword><Keyword MajorTopicYN="N">molecular mechanism</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword><Keyword MajorTopicYN="N">systemic effects</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>4</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33919537</ArticleId><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="doi">10.3390/v13040700</ArticleId><ArticleId IdType="pii">v13040700</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., et al. Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;588:E6. doi: 10.1038/s41586-020-2951-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2951-z</ArticleId><ArticleId IdType="pmc">PMC9744119</ArticleId><ArticleId IdType="pubmed">33199918</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauci A.S., Lane H.C., Redfield R.R. Covid-19&#x2014;Navigating the uncharted. N. Engl. J. Med. 2020;382:1268&#x2013;1269. doi: 10.1056/NEJMe2002387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2002387</ArticleId><ArticleId IdType="pmc">PMC7121221</ArticleId><ArticleId IdType="pubmed">32109011</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  Coronavirus Disease (Covid-2019) Situation Report&#x2014;163.  [(accessed on 1 April 2021)];2020  Available online:  https://apps.who.int/iris/bitstream/handle/10665/332971/nCoVsitrep01Jul2020-eng.pdf?sequence=1&amp;isAllowed=y.</Citation></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A novel coronavirus from patients with pneumonia in china, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Khan H., Khan S., Nawaz M. Epidemiological and clinical characteristics of coronavirus disease (Covid-19) cases at a screening clinic during the early outbreak period: A single-centre study. J. Med. Microbiol. 2020;69:1114&#x2013;1123. doi: 10.1099/jmm.0.001231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001231</ArticleId><ArticleId IdType="pmc">PMC7642977</ArticleId><ArticleId IdType="pubmed">32783802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey P., Agarwal S., Rajkumar Lung pathology in Covid-19: A systematic review. Int. J. Appl. Basic Med. Res. 2020;10:226&#x2013;233. doi: 10.4103/ijabmr.IJABMR_381_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijabmr.IJABMR_381_20</ArticleId><ArticleId IdType="pmc">PMC7758785</ArticleId><ArticleId IdType="pubmed">33376694</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., Wang H., Wan J., Wang X., Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (Covid-19) JAMA Cardiol. 2020;5:811&#x2013;818. doi: 10.1001/jamacardio.2020.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Meiler S., Hamer O.W., Schaible J., Zeman F., Zorger N., Kleine H., Rennert J., Stroszczynski C., Poschenrieder F. Computed tomography characterization and outcome evaluation of Covid-19 pneumonia complicated by venous thromboembolism. PLoS ONE. 2020;15:e0242475. doi: 10.1371/journal.pone.0242475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242475</ArticleId><ArticleId IdType="pmc">PMC7676698</ArticleId><ArticleId IdType="pubmed">33211737</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung T.Y.M., Chan A.Y.L., Chan E.W., Chan V.K.Y., Chui C.S.L., Cowling B.J., Gao L., Ge M.Q., Hung I.F.N., Ip M.S.M., et al. Short- and potential long-term adverse health outcomes of Covid-19: A rapid review. Emerg. Microbes Infect. 2020;9:2190&#x2013;2199. doi: 10.1080/22221751.2020.1825914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1825914</ArticleId><ArticleId IdType="pmc">PMC7586446</ArticleId><ArticleId IdType="pubmed">32940572</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitiello A., Ferrara F. Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19. Life Sci. 2020;262:118510. doi: 10.1016/j.lfs.2020.118510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118510</ArticleId><ArticleId IdType="pmc">PMC7521881</ArticleId><ArticleId IdType="pubmed">32991879</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade B.S., Rangel F.S., Santos N.O., Freitas A.D.S., Soares W.R.A., Siqueira S., Barh D., Goes-Neto A., Birbrair A., Azevedo V.A.C. Repurposing approved drugs for guiding Covid-19 prophylaxis: A systematic review. Front. Pharmacol. 2020;11:590598. doi: 10.3389/fphar.2020.590598.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.590598</ArticleId><ArticleId IdType="pmc">PMC7772842</ArticleId><ArticleId IdType="pubmed">33390967</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y., Ji W., Yang H., Chen S., Zhang W., Duan G. Endothelial activation and dysfunction in Covid-19: From basic mechanisms to potential therapeutic approaches. Signal. Transduct. Target. Ther. 2020;5:293. doi: 10.1038/s41392-020-00454-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00454-7</ArticleId><ArticleId IdType="pmc">PMC7758411</ArticleId><ArticleId IdType="pubmed">33361764</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G., Pinney S.P., Lala A., Reddy V.Y., Johnston-Cox H.A., Mechanick J.I., Halperin J.L., Fuster V. Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: Jacc focus seminar. J. Am. Coll. Cardiol. 2020;76:2011&#x2013;2023. doi: 10.1016/j.jacc.2020.08.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.059</ArticleId><ArticleId IdType="pmc">PMC7572122</ArticleId><ArticleId IdType="pubmed">33092737</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen L.A., Geldhof V., Pasut A., Carmeliet P. Covid-19: The vasculature unleashed. Nat. Rev. Immunol. 2020;20:389&#x2013;391. doi: 10.1038/s41577-020-0343-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0343-0</ArticleId><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosse C., Grosse A., Salzer H.J.F., Dunser M.W., Motz R., Langer R. Analysis of cardiopulmonary findings in Covid-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc. Pathol. 2020;49:107263. doi: 10.1016/j.carpath.2020.107263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107263</ArticleId><ArticleId IdType="pmc">PMC7365076</ArticleId><ArticleId IdType="pubmed">32784110</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., the Northwell C.-R.C., Barnaby D.P., Becker L.B., Chelico J.D., et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with Covid-19 in the new york city area. JAMA. 2020;323:2052&#x2013;2059. doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafi S., Rajaei E., Moallemian R., Nokhostin F. The potential similarities of Covid-19 and autoimmune disease pathogenesis and therapeutic options: New insights approach. Clin. Rheumatol. 2020;39:3223&#x2013;3235. doi: 10.1007/s10067-020-05376-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05376-x</ArticleId><ArticleId IdType="pmc">PMC7471540</ArticleId><ArticleId IdType="pubmed">32885345</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P.P., Blet A., Smyth D., Li H. The science underlying Covid-19: Implications for the cardiovascular system. Circulation. 2020;142:68&#x2013;78. doi: 10.1161/CIRCULATIONAHA.120.047549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047549</ArticleId><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Palaskas N.L., Koutroumpakis E., Deswal A. Covid-19 and cardiovascular health among patients with cancer. Curr. Cardiol. Rep. 2020;22:171. doi: 10.1007/s11886-020-01421-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-020-01421-y</ArticleId><ArticleId IdType="pmc">PMC7547820</ArticleId><ArticleId IdType="pubmed">33040241</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher R., Breakey N., Lammle B. Severe Covid-19 infection associated with endothelial activation. Thromb. Res. 2020;190:62. doi: 10.1016/j.thromres.2020.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.014</ArticleId><ArticleId IdType="pmc">PMC7156948</ArticleId><ArticleId IdType="pubmed">32305740</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in Covid-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., Wang K., Viveiros A., Nguyen Q., Zhong J.C., Turner A.J., Raizada M.K., Grant M.B., Oudit G.Y. Angiotensin-converting enzyme 2: Sars-cov-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ace2. Circ. Res. 2020;126:1456&#x2013;1474. doi: 10.1161/CIRCRESAHA.120.317015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317015</ArticleId><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Oudit G.Y., Kassiri Z., Jiang C., Liu P.P., Poutanen S.M., Penninger J.M., Butany J. Sars-coronavirus modulation of myocardial ace2 expression and inflammation in patients with sars. Eur. J. Clin. Investig. 2009;39:618&#x2013;625. doi: 10.1111/j.1365-2362.2009.02153.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2009.02153.x</ArticleId><ArticleId IdType="pmc">PMC7163766</ArticleId><ArticleId IdType="pubmed">19453650</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Cooper M.E., Haagmans B.L., Hooper N.M., Korstanje R., Osterhaus A.D., Timens W., Turner A.J., Navis G., van Goor H. The emerging role of ace2 in physiology and disease. J. Pathol. 2007;212:1&#x2013;11. doi: 10.1002/path.2162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2162</ArticleId><ArticleId IdType="pmc">PMC7167724</ArticleId><ArticleId IdType="pubmed">17464936</ArticleId></ArticleIdList></Reference><Reference><Citation>Chansrichavala P., Chantharaksri U., Sritara P., Chaiyaroj S.C. Atorvastatin attenuates tlr4-mediated nf-kappab activation in a myd88-dependent pathway. Asian Pac. J. Allergy Immunol. 2009;27:49&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">19548630</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheahan T., Morrison T.E., Funkhouser W., Uematsu S., Akira S., Baric R.S., Heise M.T. Myd88 is required for protection from lethal infection with a mouse-adapted sars-cov. PLoS Pathog. 2008;4:e1000240. doi: 10.1371/journal.ppat.1000240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000240</ArticleId><ArticleId IdType="pmc">PMC2587915</ArticleId><ArticleId IdType="pubmed">19079579</ArticleId></ArticleIdList></Reference><Reference><Citation>DeDiego M.L., Nieto-Torres J.L., Regla-Nava J.A., Jimenez-Guardeno J.M., Fernandez-Delgado R., Fett C., Castano-Rodriguez C., Perlman S., Enjuanes L. Inhibition of nf-kappab-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J. Virol. 2014;88:913&#x2013;924. doi: 10.1128/JVI.02576-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02576-13</ArticleId><ArticleId IdType="pmc">PMC3911641</ArticleId><ArticleId IdType="pubmed">24198408</ArticleId></ArticleIdList></Reference><Reference><Citation>Rios J.L. Effects of triterpenes on the immune system. J. Ethnopharmacol. 2010;128:1&#x2013;14. doi: 10.1016/j.jep.2009.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2009.12.045</ArticleId><ArticleId IdType="pubmed">20079412</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaestel M., Kotlyarov A., Kracht M. Targeting innate immunity protein kinase signalling in inflammation. Nat. Rev. Drug Discov. 2009;8:480&#x2013;499. doi: 10.1038/nrd2829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd2829</ArticleId><ArticleId IdType="pubmed">19483709</ArticleId></ArticleIdList></Reference><Reference><Citation>Barh D., Tiwari S., Andrade B.S., Weener M.E., Goes-Neto A., Azevedo V., Ghosh P., Blum K., Ganguly N.K. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of Covid-19. Mol. Omics. 2021 doi: 10.1039/D0MO00189A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0MO00189A</ArticleId><ArticleId IdType="pubmed">33683246</ArticleId></ArticleIdList></Reference><Reference><Citation>Baas J., Schotten M., Plume A., C&#xf4;t&#xe9; G., Karimi R. Scopus as a curated, high-quality bibliometric data source for academic research in quantitative science studies. Quant. Sci. Stud. 2020;1:377&#x2013;386. doi: 10.1162/qss_a_00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/qss_a_00019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballew B.S. Elsevier&#x2019;s scopus&#xae; database. J. Electron. Resour. Med. Librar. 2009;6:245&#x2013;252. doi: 10.1080/15424060903167252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15424060903167252</ArticleId></ArticleIdList></Reference><Reference><Citation>Canas C.A. The triggering of post-Covid-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Med. Hypotheses. 2020;145:110345. doi: 10.1016/j.mehy.2020.110345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110345</ArticleId><ArticleId IdType="pmc">PMC7556280</ArticleId><ArticleId IdType="pubmed">33080459</ArticleId></ArticleIdList></Reference><Reference><Citation>Loarce-Martos J., Garcia-Fernandez A., Lopez-Gutierrez F., Garcia-Garcia V., Calvo-Sanz L., Del Bosque-Granero I., Teran-Tinedo M.A., Boteanu A., Bachiller-Corral J., Vazquez-Diaz M. High rates of severe disease and death due to sars-cov-2 infection in rheumatic disease patients treated with rituximab: A descriptive study. Rheumatol. Int. 2020;40:2015&#x2013;2021. doi: 10.1007/s00296-020-04699-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04699-x</ArticleId><ArticleId IdType="pmc">PMC7499013</ArticleId><ArticleId IdType="pubmed">32945944</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Larco R.M., Altez-Fernandez C., Ravaglia S., Vizcarra J.A. Covid-19 and guillain-barre syndrome: A systematic review of case reports. Wellcome Open Res. 2020;5:107. doi: 10.12688/wellcomeopenres.15987.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.15987.2</ArticleId><ArticleId IdType="pmc">PMC7509591</ArticleId><ArticleId IdType="pubmed">32995555</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanalakshmi K., Venkataraman A., Balasubramanian S., Madhusudan M., Amperayani S., Putilibai S., Sadasivam K., Ramachandran B., Ramanan A.V. Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome&#x2014;Temporally associated with sars-cov-2 (pims-ts) in indian children. Indian Pediatr. 2020;57:1010&#x2013;1014. doi: 10.1007/s13312-020-2025-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13312-020-2025-1</ArticleId><ArticleId IdType="pmc">PMC7678572</ArticleId><ArticleId IdType="pubmed">32769230</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedaghat Z., Karimi N. Guillain barre syndrome associated with Covid-19 infection: A case report. J. Clin. Neurosci. 2020;76:233&#x2013;235. doi: 10.1016/j.jocn.2020.04.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.04.062</ArticleId><ArticleId IdType="pmc">PMC7158817</ArticleId><ArticleId IdType="pubmed">32312628</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Manzanedo S., Lopez de la Oliva Calvo L., Ruiz Alvarez L. Guillain-barre syndrome after Covid-19 infection. Med. Clin. 2020;155:366. doi: 10.1016/j.medcli.2020.06.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2020.06.023</ArticleId><ArticleId IdType="pmc">PMC7526591</ArticleId><ArticleId IdType="pubmed">33020737</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri C., Giuggioli D., Raimondo V., L&#x2019;Andolina M., Tavoni A., Cecchetti R., Guiducci S., Ursini F., Caminiti M., Varcasia G., et al. Covid-19 and rheumatic autoimmune systemic diseases: Report of a large italian patients series. Clin. Rheumatol. 2020;39:3195&#x2013;3204. doi: 10.1007/s10067-020-05334-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05334-7</ArticleId><ArticleId IdType="pmc">PMC7450255</ArticleId><ArticleId IdType="pubmed">32852623</ArticleId></ArticleIdList></Reference><Reference><Citation>Veenstra J., Buechler C.R., Robinson G., Chapman S., Adelman M., Tisack A., Dimitrion P., Todter E., Kohen L., Lim H.W. Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a Covid-19 outbreak. J. Am. Acad. Dermatol. 2020;83:1696&#x2013;1703. doi: 10.1016/j.jaad.2020.07.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.07.089</ArticleId><ArticleId IdType="pmc">PMC7385924</ArticleId><ArticleId IdType="pubmed">32735965</ArticleId></ArticleIdList></Reference><Reference><Citation>Pablos J.L., Galindo M., Carmona L., Lledo A., Retuerto M., Blanco R., Gonzalez-Gay M.A., Martinez-Lopez D., Castrejon I., Alvaro-Gracia J.M., et al. Clinical outcomes of hospitalised patients with Covid-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study. Ann. Rheum. Dis. 2020;79:1544&#x2013;1549. doi: 10.1136/annrheumdis-2020-218296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218296</ArticleId><ArticleId IdType="pubmed">32796045</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberman R.H., Castillo R., Chen A., Yan D., Ramirez D., Sekar V., Lesser R., Solomon G., Neimann A.L., Blank R.B., et al. Covid-19 in patients with inflammatory arthritis: A prospective study on the effects of comorbidities and disease-modifying antirheumatic drugs on clinical outcomes. Arthritis Rheumatol. 2020;72:1981&#x2013;1989. doi: 10.1002/art.41456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41456</ArticleId><ArticleId IdType="pmc">PMC7722024</ArticleId><ArticleId IdType="pubmed">32725762</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassen L.M., Almaghlouth I.A., Hassen I.M., Daghestani M.H., Almohisen A.A., Alqurtas E.M., Alkhalaf A., Bedaiwi M.K., Omair M.A., Almogairen S.M., et al. Impact of Covid-19 outbreak on rheumatic patients&#x2019; perceptions and behaviors: A cross-sectional study. Int. J. Rheum. Dis. 2020;23:1541&#x2013;1549. doi: 10.1111/1756-185X.13959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13959</ArticleId><ArticleId IdType="pubmed">32940963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadanandam A., Bopp T., Dixit S., Knapp D., Emperumal C.P., Vergidis P., Rajalingam K., Melcher A., Kannan N. A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients. Cell Death Discov. 2020;6:141. doi: 10.1038/s41420-020-00376-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-020-00376-x</ArticleId><ArticleId IdType="pmc">PMC7721861</ArticleId><ArticleId IdType="pubmed">33293514</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves L.F., Gonzales A.I., Patatt F.S.A., Paiva K.M., Haas P. Kawasaki and Covid-19 disease in children: A systematic review. Rev. Assoc. Med. Bras. 2020;66(Suppl. S2):136&#x2013;142. doi: 10.1590/1806-9282.66.s2.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.66.s2.136</ArticleId><ArticleId IdType="pubmed">32965372</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S., Danda D., Kavadichanda C., Das S., Adarsh M.B., Negi V.S. Autoimmune and rheumatic musculoskeletal diseases as a consequence of sars-cov-2 infection and its treatment. Rheumatol. Int. 2020;40:1539&#x2013;1554. doi: 10.1007/s00296-020-04639-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-020-04639-9</ArticleId><ArticleId IdType="pmc">PMC7360125</ArticleId><ArticleId IdType="pubmed">32666137</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachariah U., Nair S.C., Goel A., Balasubramanian K.A., Mackie I., Elias E., Eapen C.E. Targeting raised von willebrand factor levels and macrophage activation in severe Covid-19: Consider low volume plasma exchange and low dose steroid. Thromb. Res. 2020;192:2. doi: 10.1016/j.thromres.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7198395</ArticleId><ArticleId IdType="pubmed">32403033</ArticleId></ArticleIdList></Reference><Reference><Citation>Aird W.C. Phenotypic heterogeneity of the endothelium: Ii. Representative vascular beds. Circ. Res. 2007;100:174&#x2013;190. doi: 10.1161/01.RES.0000255690.03436.ae.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000255690.03436.ae</ArticleId><ArticleId IdType="pubmed">17272819</ArticleId></ArticleIdList></Reference><Reference><Citation>Boisrame-Helms J., Kremer H., Schini-Kerth V., Meziani F. Endothelial dysfunction in sepsis. Curr. Vasc. Pharmacol. 2013;11:150&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">23506494</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobos-Siles M., Cubero-Morais P., Arroyo-Jimenez I., Rey-Hernandez M., Hernandez-Gomez L., Vargas-Parra D.J., Gonzalez-Fernandez M., Cazorla-Gonzalez M., Gabella-Martin M., Ruiz-Albi T., et al. Cause-specific death in hospitalized individuals infected with sars-cov-2: More than just acute respiratory failure or thromboembolic events. Intern. Emerg. Med. 2020;15:1533&#x2013;1544. doi: 10.1007/s11739-020-02485-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02485-y</ArticleId><ArticleId IdType="pmc">PMC7481346</ArticleId><ArticleId IdType="pubmed">32910363</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Errico S., Zanon M., Montanaro M., Radaelli D., Sessa F., Di Mizio G., Montana A., Corrao S., Salerno M., Pomara C. More than pneumonia: Distinctive features of sars-cov-2 infection. From autopsy findings to clinical implications: A systematic review. Microorganisms. 2020;8:1642. doi: 10.3390/microorganisms8111642.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8111642</ArticleId><ArticleId IdType="pmc">PMC7690727</ArticleId><ArticleId IdType="pubmed">33114061</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Qin M., Cai Y., Liu T., Shen B., Yang F., Cao S., Liu X., Xiang Y., Zhao Q., et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur. Heart J. 2020;41:2070&#x2013;2079. doi: 10.1093/eurheartj/ehaa408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa408</ArticleId><ArticleId IdType="pmc">PMC7239100</ArticleId><ArticleId IdType="pubmed">32391877</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319&#x2013;1325. doi: 10.1016/S0140-6736(03)13077-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13077-2</ArticleId><ArticleId IdType="pmc">PMC7112372</ArticleId><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, china. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khawaga S., Abdelalim E.M. Potential application of mesenchymal stem cells and their exosomes in lung injury: An emerging therapeutic option for Covid-19 patients. Stem Cell Res. Ther. 2020;11:437. doi: 10.1186/s13287-020-01963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-020-01963-6</ArticleId><ArticleId IdType="pmc">PMC7558244</ArticleId><ArticleId IdType="pubmed">33059757</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G., Campia U., Hurwitz S., Snyder J.E., Rizzo S.M., Pfeferman M.B., Morrison R.B., Leiva O., Fanikos J., Nauffal V., et al. Registry of arterial and venous thromboembolic complications in patients with Covid-19. J. Am. Coll. Cardiol. 2020;76:2060&#x2013;2072. doi: 10.1016/j.jacc.2020.08.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.070</ArticleId><ArticleId IdType="pmc">PMC7588178</ArticleId><ArticleId IdType="pubmed">33121712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y., Giovini M., Leone M., Pizzilli G., Kortgen A., Bauer M., Tonetti T., Duclos G., Zieleskiewicz L., Buschbeck S., et al. Pulmonary embolism in patients with coronavirus disease-2019 (Covid-19) pneumonia: A narrative review. Ann. Intensive Care. 2020;10:124. doi: 10.1186/s13613-020-00741-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00741-0</ArticleId><ArticleId IdType="pmc">PMC7492788</ArticleId><ArticleId IdType="pubmed">32953201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidarta-Oliveira D., Jara C.P., Ferruzzi A.J., Skaf M.S., Velander W.H., Araujo E.P., Velloso L.A. Sars-cov-2 receptor is co-expressed with elements of the kinin-kallikrein, renin-angiotensin and coagulation systems in alveolar cells. Sci. Rep. 2020;10:19522. doi: 10.1038/s41598-020-76488-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76488-2</ArticleId><ArticleId IdType="pmc">PMC7658217</ArticleId><ArticleId IdType="pubmed">33177594</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii H., Tsuji T., Yuba T., Tanaka S., Suga Y., Matsuyama A., Omura A., Shiotsu S., Takumi C., Ono S., et al. High levels of anti-ssa/ro antibodies in Covid-19 patients with severe respiratory failure: A case-based review: High levels of anti-ssa/ro antibodies in Covid-19. Clin. Rheumatol. 2020;39:3171&#x2013;3175. doi: 10.1007/s10067-020-05359-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05359-y</ArticleId><ArticleId IdType="pmc">PMC7447083</ArticleId><ArticleId IdType="pubmed">32844364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.W.X., Rajai A., Patel R., Gerova N., Godhamgaonkar V., Liong S.Y. Pulmonary thromboembolic disease in Covid-19 patients on ct pulmonary angiography&#x2014;Prevalence, pattern of disease and relationship to d-dimer. Eur. J. Radiol. 2020;132:109336. doi: 10.1016/j.ejrad.2020.109336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.109336</ArticleId><ArticleId IdType="pmc">PMC7537636</ArticleId><ArticleId IdType="pubmed">33069986</ArticleId></ArticleIdList></Reference><Reference><Citation>Uppuluri E.M., Shapiro N.L. Development of pulmonary embolism in a nonhospitalized patient with Covid-19 who did not receive venous thromboembolism prophylaxis. Am. J. Health Syst. Pharm. 2020;77:1957&#x2013;1960. doi: 10.1093/ajhp/zxaa286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajhp/zxaa286</ArticleId><ArticleId IdType="pmc">PMC7454312</ArticleId><ArticleId IdType="pubmed">32780839</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisano T.J., Joki J., Hon B., Cuccurullo S. Pulmonary embolism after acute spinal cord injury and Covid-19. Am. J. Phys. Med. Rehabil. 2020;99:982&#x2013;985. doi: 10.1097/PHM.0000000000001578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001578</ArticleId><ArticleId IdType="pmc">PMC7526399</ArticleId><ArticleId IdType="pubmed">32858533</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Barratt S.L., Condliffe R., Desai S.R., Devaraj A., Forrest I., Gibbons M.A., Hart N., Jenkins R.G., McAuley D.F., et al. Respiratory follow-up of patients with Covid-19 pneumonia. Thorax. 2020;75:1009&#x2013;1016. doi: 10.1136/thoraxjnl-2020-215314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215314</ArticleId><ArticleId IdType="pubmed">32839287</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kruijsdijk R.C., de Jong P.A., Abrahams A.C. Pulmonary vein thrombosis in Covid-19. BMJ Case Rep. 2020;13:e239986. doi: 10.1136/bcr-2020-239986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-239986</ArticleId><ArticleId IdType="pmc">PMC10577703</ArticleId><ArticleId IdType="pubmed">33130591</ArticleId></ArticleIdList></Reference><Reference><Citation>Korkmaz B., Lesner A., Marchand-Adam S., Moss C., Jenne D.E. Lung protection by cathepsin c inhibition: A new hope for Covid-19 and ards? J. Med. Chem. 2020;63:13258&#x2013;13265. doi: 10.1021/acs.jmedchem.0c00776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.0c00776</ArticleId><ArticleId IdType="pubmed">32692176</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillai P., Joseph J.P., Fadzillah N.H.M., Mahmod M. Covid-19 and major organ thromboembolism: Manifestations in neurovascular and cardiovascular systems. J. Stroke Cerebrovasc. Dis. 2021;30:105427. doi: 10.1016/j.jstrokecerebrovasdis.2020.105427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105427</ArticleId><ArticleId IdType="pmc">PMC7584882</ArticleId><ArticleId IdType="pubmed">33137615</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.Z., Jamal Y., Sutton B., Rauf F. Venous thromboembolism in patients with Covid-19 and correlation with d-dimers: A single-centre experience. BMJ Open Respir. Res. 2020;7:e000779. doi: 10.1136/bmjresp-2020-000779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2020-000779</ArticleId><ArticleId IdType="pmc">PMC7670550</ArticleId><ArticleId IdType="pubmed">33199402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T., Narazaki M., Kishimoto T. Immunotherapeutic implications of il-6 blockade for cytokine storm. Immunotherapy. 2016;8:959&#x2013;970. doi: 10.2217/imt-2016-0020.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/imt-2016-0020</ArticleId><ArticleId IdType="pubmed">27381687</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth C.M., Matukas L.M., Tomlinson G.A., Rachlis A.R., Rose D.B., Dwosh H.A., Walmsley S.L., Mazzulli T., Avendano M., Derkach P., et al. Clinical features and short-term outcomes of 144 patients with Sars in the greater Toronto area. JAMA. 2003;289:2801&#x2013;2809. doi: 10.1001/jama.289.21.JOC30885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.21.JOC30885</ArticleId><ArticleId IdType="pubmed">12734147</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawi A., Ryoo S.G. Prevalence of comorbidities in the middle east respiratory syndrome coronavirus (mers-cov): A systematic review and meta-analysis. Int. J. Infect. Dis. 2016;49:129&#x2013;133. doi: 10.1016/j.ijid.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2016.06.015</ArticleId><ArticleId IdType="pmc">PMC7110556</ArticleId><ArticleId IdType="pubmed">27352628</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 2004;351:2611&#x2013;2618. doi: 10.1056/NEJMoa041747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa041747</ArticleId><ArticleId IdType="pubmed">15602021</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Yang J., Zhao F., Zhi L., Wang X., Liu L., Bi Z., Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on Covid-19 in china. Clin. Res. Cardiol. 2020;109:531&#x2013;538. doi: 10.1007/s00392-020-01626-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01626-9</ArticleId><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A., White H.D., Executive Group on behalf of the Joint European Society of Cardiology/American College of Cardiology/American Heart Association/World Heart Federation Task Force for the Universal Definition of Myocardial, I Fourth universal definition of myocardial infarction (2018) Circulation. 2018;138:e618&#x2013;e651. doi: 10.1161/CIR.0000000000000617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000617</ArticleId><ArticleId IdType="pubmed">30571511</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Veerdonk F.L., Netea M.G., Dinarello C.A., Joosten L.A. Inflammasome activation and il-1beta and il-18 processing during infection. Trends Immunol. 2011;32:110&#x2013;116. doi: 10.1016/j.it.2011.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2011.01.003</ArticleId><ArticleId IdType="pubmed">21333600</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallance P., Collier J., Bhagat K. Infection, inflammation, and infarction: Does acute endothelial dysfunction provide a link? Lancet. 1997;349:1391&#x2013;1392. doi: 10.1016/S0140-6736(96)09424-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)09424-X</ArticleId><ArticleId IdType="pubmed">9149715</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin J.F., Almansa R., Torres A., Gonzalez-Rivera M., Kelvin D.J. Covid-19 as a cardiovascular disease: The potential role of chronic endothelial dysfunction. Cardiovasc. Res. 2020;116:e132&#x2013;e133. doi: 10.1093/cvr/cvaa140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa140</ArticleId><ArticleId IdType="pmc">PMC7314234</ArticleId><ArticleId IdType="pubmed">32420587</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkisian L., Saaby L., Poulsen T.S., Gerke O., Jangaard N., Hosbond S., Diederichsen A.C., Thygesen K., Mickley H. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am. J. Med. 2016;129:446.e5&#x2013;446.e21. doi: 10.1016/j.amjmed.2015.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2015.11.006</ArticleId><ArticleId IdType="pubmed">26593739</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira R., Santos M., Gil V. Covid-19 and cardiovascular comorbidities: An update. Rev. Port. Cardiol. 2020;39:417&#x2013;419. doi: 10.1016/j.repc.2020.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.repc.2020.06.013</ArticleId><ArticleId IdType="pmc">PMC7832377</ArticleId><ArticleId IdType="pubmed">38620731</ArticleId></ArticleIdList></Reference><Reference><Citation>Moderato L., Monello A., Lazzeroni D., Binno S., Giacalone R., Ferraro S., Piepoli M.F., Villani G.Q. Takotsubo syndrome during sars-cov-2 pneumonia: A possible cardiovascular complication. G. Ital. Cardiol. 2020;21:417&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">32425184</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhou L., Hu Z., Zhang S., Yang S., Tao Y., Xie C., Ma K., Shang K., Wang W., et al. Dysregulation of immune response in patients with coronavirus 2019 (Covid-19) in Wuhan, China. Clin. Infect. Dis. 2020;71:762&#x2013;768. doi: 10.1093/cid/ciaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobai I.A., Edgecomb J., LaBarge K., Colucci W.S. Dysregulation of intracellular calcium transporters in animal models of sepsis-induced cardiomyopathy. Shock. 2015;43:3&#x2013;15. doi: 10.1097/SHK.0000000000000261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000261</ArticleId><ArticleId IdType="pmc">PMC4269564</ArticleId><ArticleId IdType="pubmed">25186837</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds H.R., Adhikari S., Pulgarin C., Troxel A.B., Iturrate E., Johnson S.B., Hausvater A., Newman J.D., Berger J.S., Bangalore S., et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N. Engl. J. Med. 2020;382:2441&#x2013;2448. doi: 10.1056/NEJMoa2008975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2008975</ArticleId><ArticleId IdType="pmc">PMC7206932</ArticleId><ArticleId IdType="pubmed">32356628</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott A.J., O&#x2019;Dea K.P., O&#x2019;Callaghan D., Williams L., Dokpesi J.O., Tatton L., Handy J.M., Hogg P.J., Takata M. Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor alpha-converting enzyme (tace/adam-17) activation in primary human monocytes. J. Biol. Chem. 2011;286:35466&#x2013;35476. doi: 10.1074/jbc.M111.277434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.277434</ArticleId><ArticleId IdType="pmc">PMC3195581</ArticleId><ArticleId IdType="pubmed">21865167</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel V.B., Clarke N., Wang Z., Fan D., Parajuli N., Basu R., Putko B., Kassiri Z., Turner A.J., Oudit G.Y. Angiotensin ii induced proteolytic cleavage of myocardial ace2 is mediated by tace/adam-17: A positive feedback mechanism in the ras. J. Mol. Cell Cardiol. 2014;66:167&#x2013;176. doi: 10.1016/j.yjmcc.2013.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2013.11.017</ArticleId><ArticleId IdType="pubmed">24332999</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G., Pellegrini C., Maurelli M., Belliato M., Sciutti F., Bottazzi A., Sepe P.A., Resasco T., Camporotondo R., Bruno R., et al. Myocardial localization of coronavirus in Covid-19 cardiogenic shock. Eur. J. Heart Fail. 2020;22:911&#x2013;915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel P., Kopp S., Gobel S., Jansen T., Geyer M., Hahn F., Kreitner K.F., Escher F., Schultheiss H.P., Munzel T. Evidence of sars-cov-2 mrna in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for Covid-19 in nasopharyngeal swab. Cardiovasc. Res. 2020;116:1661&#x2013;1663. doi: 10.1093/cvr/cvaa160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa160</ArticleId><ArticleId IdType="pmc">PMC7337685</ArticleId><ArticleId IdType="pubmed">32562489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Yu Y.L., Li W., Liu Y., Lu J.X., Chen F., Zhou Q., Xia Z.Y., Gao L., Meng Q.T., et al. Gastrointestinal symptoms associated with unfavorable prognosis of Covid-19 patients: A retrospective study. Front. Med. 2020;7:608259. doi: 10.3389/fmed.2020.608259.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.608259</ArticleId><ArticleId IdType="pmc">PMC7686879</ArticleId><ArticleId IdType="pubmed">33262996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L.B., Pang R.R., Qiao Q.H., Wang Z.H., Xia X.Y., Wang C.J., Xu X.L. Successful recovery of Covid-19-associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma. Mil. Med. Res. 2020;7:45. doi: 10.1186/s40779-020-00273-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40779-020-00273-5</ArticleId><ArticleId IdType="pmc">PMC7508641</ArticleId><ArticleId IdType="pubmed">32962760</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong P., Xu J., Yang D., Shen Y., Wang L., Feng Y., Du C., Song Y., Wu C., Hu X., et al. Covid-19-associated gastrointestinal and liver injury: Clinical features and potential mechanisms. Signal. Transduct. Target. Ther. 2020;5:256. doi: 10.1038/s41392-020-00373-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00373-7</ArticleId><ArticleId IdType="pmc">PMC7605138</ArticleId><ArticleId IdType="pubmed">33139693</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilal M., Sawhney M.S., Feuerstein J.D. Coronavirus disease-2019: Implications for the gastroenterologist. Curr. Opin. Gastroenterol. 2021;37:23&#x2013;29. doi: 10.1097/MOG.0000000000000694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0000000000000694</ArticleId><ArticleId IdType="pubmed">33074995</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin T.A., Wan D.W., Hajifathalian K., Tewani S., Shah S.L., Mehta A., Kaplan A., Ghosh G., Choi A.J., Krisko T.I., et al. Gastrointestinal bleeding in patients with coronavirus disease 2019: A matched case-control study. Am. J. Gastroenterol. 2020;115:1609&#x2013;1616. doi: 10.14309/ajg.0000000000000805.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000805</ArticleId><ArticleId IdType="pmc">PMC7446989</ArticleId><ArticleId IdType="pubmed">32796176</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmohsen M.A., Alkandari B.M., Gupta V.K., ElBeheiry A.A. Diagnostic value of abdominal sonography in confirmed Covid-19 intensive care patients. Egypt. J. Radiol. Nucl. Med. 2020;51:1&#x2013;7. doi: 10.1186/s43055-020-00317-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43055-020-00317-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Villapol S. Gastrointestinal symptoms associated with Covid-19: Impact on the gut microbiome. Transl. Res. 2020;226:57&#x2013;69. doi: 10.1016/j.trsl.2020.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.08.004</ArticleId><ArticleId IdType="pmc">PMC7438210</ArticleId><ArticleId IdType="pubmed">32827705</ArticleId></ArticleIdList></Reference><Reference><Citation>Vodnar D.C., Mitrea L., Teleky B.E., Szabo K., Calinoiu L.F., Nemes S.A., Martau G.A. Coronavirus disease (Covid-19) caused by (sars-cov-2) infections: A real challenge for human gut microbiota. Front. Cell Infect. Microbiol. 2020;10:575559. doi: 10.3389/fcimb.2020.575559.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.575559</ArticleId><ArticleId IdType="pmc">PMC7756003</ArticleId><ArticleId IdType="pubmed">33363049</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber T.K., Leandro-Merhi V.A., Bernasconi I., Oliveira M.R.M. Nutritional therapy in hospital care of in-patients with Covid-19: Evidence, consensus and practice guidelines. Rev. Nutr. 2020:e200212. doi: 10.1590/1678-9865202033e200212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1678-9865202033e200212</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Z.Y., Xiang B.J., Jiang M., Sun M.J., Dai C. The prevalence of gastrointestinal symptoms, abnormal liver function, digestive system disease and liver disease in Covid-19 infection: A systematic review and meta-analysis. J. Clin. Gastroenterol. 2021;55:67&#x2013;76. doi: 10.1097/MCG.0000000000001424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0000000000001424</ArticleId><ArticleId IdType="pmc">PMC7713642</ArticleId><ArticleId IdType="pubmed">33116063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.G., Cui H.R., Tang H.B., Deng X.L. Gastrointestinal symptoms and fecal nucleic acid testing of children with 2019 coronavirus disease: A systematic review and meta-analysis. Sci. Rep. 2020;10:17846. doi: 10.1038/s41598-020-74913-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74913-0</ArticleId><ArticleId IdType="pmc">PMC7576139</ArticleId><ArticleId IdType="pubmed">33082472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q., Wang B., Zhang T., Xu J., Shang S. The mechanism and treatment of gastrointestinal symptoms in patients with Covid-19. Am. J. Physiol Gastrointest Liver Physiol. 2020;319:G245&#x2013;G252. doi: 10.1152/ajpgi.00148.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00148.2020</ArticleId><ArticleId IdType="pmc">PMC7414235</ArticleId><ArticleId IdType="pubmed">32639848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanathan M., Chueng T., Fernandez E., Gonzales-Zamora J. Concomitant renal and splenic infarction as a complication of Covid-19: A case report and literature review. Infez Med. 2020;28:611&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257638</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya S., Anwar S., Siddiqui F.S., Shabih S., Manchandani U., Dalezman S. Renal artery thrombosis in Covid-19. IDCases. 2020;22:e00968. doi: 10.1016/j.idcr.2020.e00968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2020.e00968</ArticleId><ArticleId IdType="pmc">PMC7518798</ArticleId><ArticleId IdType="pubmed">33014708</ArticleId></ArticleIdList></Reference><Reference><Citation>Idilman I.S., Telli Dizman G., Ardali Duzgun S., Irmak I., Karcaaltincaba M., Inkaya A.C., Demirkazik F., Durhan G., Gulsun Akpinar M., Ariyurek O.M., et al. Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with Covid-19-related systemic microangiopathy. Eur. Radiol. 2021;31:1090&#x2013;1099. doi: 10.1007/s00330-020-07155-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-07155-3</ArticleId><ArticleId IdType="pmc">PMC7455509</ArticleId><ArticleId IdType="pubmed">32860146</ArticleId></ArticleIdList></Reference><Reference><Citation>Trottein F., Sokol H. Potential causes and consequences of gastrointestinal disorders during a sars-cov-2 infection. Cell Rep. 2020;32:107915. doi: 10.1016/j.celrep.2020.107915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107915</ArticleId><ArticleId IdType="pmc">PMC7332457</ArticleId><ArticleId IdType="pubmed">32649864</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A.K., Bhushan B., Maurya A., Mishra G., Singh S.K., Awasthi R. Novel coronavirus disease 2019 (Covid-19) and neurodegenerative disorders. Dermatol. Ther. 2020;33:e13591. doi: 10.1111/dth.13591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dth.13591</ArticleId><ArticleId IdType="pmc">PMC7261984</ArticleId><ArticleId IdType="pubmed">32412679</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanghvi A.R. Covid-19: An overview for dermatologists. Int. J. Dermatol. 2020;59:1437&#x2013;1449. doi: 10.1111/ijd.15257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.15257</ArticleId><ArticleId IdType="pubmed">33107038</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahedi Niaki O., Anadkat M.J., Chen S.T., Fox L.P., Harp J., Micheletti R.G., Nambudiri V.E., Pasieka H.B., Shinohara M.M., Rosenbach M., et al. Navigating immunosuppression in a pandemic: A guide for the dermatologist from the covid task force of the medical dermatology society and society of dermatology hospitalists. J. Am. Acad. Dermatol. 2020;83:1150&#x2013;1159. doi: 10.1016/j.jaad.2020.06.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.06.051</ArticleId><ArticleId IdType="pmc">PMC7303642</ArticleId><ArticleId IdType="pubmed">32569797</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonometti R., Sacchi M.C., Stobbione P., Lauritano E.C., Tamiazzo S., Marchegiani A., Novara E., Molinaro E., Benedetti I., Massone L., et al. The first case of systemic lupus erythematosus (sle) triggered by Covid-19 infection. Eur. Rev. Med. Pharmacol. Sci. 2020;24:9695&#x2013;9697.</Citation><ArticleIdList><ArticleId IdType="pubmed">33015814</ArticleId></ArticleIdList></Reference><Reference><Citation>Gokhale Y., Patankar A., Holla U., Shilke M., Kalekar L., Karnik N.D., Bidichandani K., Baveja S., Joshi A. Dermatomyositis during Covid-19 pandemic (a case series): Is there a cause effect relationship? J. Assoc. Physicians India. 2020;68:20&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">33187031</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigro E., Polito R., Alfieri A., Mancini A., Imperlini E., Elce A., Krustrup P., Orru S., Buono P., Daniele A. Molecular mechanisms involved in the positive effects of physical activity on coping with Covid-19. Eur. J. Appl. Physiol. 2020;120:2569&#x2013;2582. doi: 10.1007/s00421-020-04484-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-020-04484-5</ArticleId><ArticleId IdType="pmc">PMC7471545</ArticleId><ArticleId IdType="pubmed">32885275</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of sars-cov2 may play a role in the respiratory failure of Covid-19 patients. J. Med. Virol. 2020;92:552&#x2013;555. doi: 10.1002/jmv.25728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Disser N.P., De Micheli A.J., Schonk M.M., Konnaris M.A., Piacentini A.N., Edon D.L., Toresdahl B.G., Rodeo S.A., Casey E.K., Mendias C.L. Musculoskeletal consequences of Covid-19. J. Bone Joint Surg. Am. 2020;102:1197&#x2013;1204. doi: 10.2106/JBJS.20.00847.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.20.00847</ArticleId><ArticleId IdType="pmc">PMC7508274</ArticleId><ArticleId IdType="pubmed">32675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Greve J.M.D., Brech G.C., Quintana M., Soares A.L.S., Alonso A.C. Impacts of Covid-19 on the immune, neuromuscular, and musculoskeletal systems and rehabilitation. Rev. Bras. Med. Esporte. 2020;26:4. doi: 10.1590/1517-869220202604esp002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1517-869220202604esp002</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following sars-cov-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau H.M., Lee E.W., Wong C.N., Ng G.Y., Jones A.Y., Hui D.S. The impact of severe acute respiratory syndrome on the physical profile and quality of life. Arch. Phys. Med. Rehabil. 2005;86:1134&#x2013;1140. doi: 10.1016/j.apmr.2004.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2004.09.025</ArticleId><ArticleId IdType="pmc">PMC7094462</ArticleId><ArticleId IdType="pubmed">15954051</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray P.B., Jr., Pewe L., Wohlford-Lenane C., Hickey M., Manzel L., Shi L., Netland J., Jia H.P., Halabi C., Sigmund C.D., et al. Lethal infection of k18-hace2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 2007;81:813&#x2013;821. doi: 10.1128/JVI.02012-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02012-06</ArticleId><ArticleId IdType="pmc">PMC1797474</ArticleId><ArticleId IdType="pubmed">17079315</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumucio J.P., Qasawa A.H., Ferrara P.J., Malik A.N., Funai K., McDonagh B., Mendias C.L. Reduced mitochondrial lipid oxidation leads to fat accumulation in myosteatosis. FASEB J. 2019;33:7863&#x2013;7881. doi: 10.1096/fj.201802457RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802457RR</ArticleId><ArticleId IdType="pmc">PMC6593892</ArticleId><ArticleId IdType="pubmed">30939247</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendias C.L., Roche S.M., Harning J.A., Davis M.E., Lynch E.B., Sibilsky Enselman E.R., Jacobson J.A., Claflin D.R., Calve S., Bedi A. Reduced muscle fiber force production and disrupted myofibril architecture in patients with chronic rotator cuff tears. J. Shoulder Elbow Surg. 2015;24:111&#x2013;119. doi: 10.1016/j.jse.2014.06.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jse.2014.06.037</ArticleId><ArticleId IdType="pubmed">25193488</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung T.W., Wong K.S., Hui A.C., To K.F., Lai S.T., Ng W.F., Ng H.K. Myopathic changes associated with severe acute respiratory syndrome: A postmortem case series. Arch. Neurol. 2005;62:1113&#x2013;1117. doi: 10.1001/archneur.62.7.1113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.62.7.1113</ArticleId><ArticleId IdType="pubmed">16009768</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in wuhan, china. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Favas T.T., Dev P., Chaurasia R.N., Chakravarty K., Mishra R., Joshi D., Mishra V.N., Kumar A., Singh V.K., Pandey M., et al. Neurological manifestations of Covid-19: A systematic review and meta-analysis of proportions. Neurol. Sci. 2020;41:3437&#x2013;3470. doi: 10.1007/s10072-020-04801-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04801-y</ArticleId><ArticleId IdType="pmc">PMC7577367</ArticleId><ArticleId IdType="pubmed">33089477</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E.M., Logsdon A.F., Hansen K.M., Williams L.M., Reed M.J., Baumann K.K., Holden S.J., Raber J., Banks W.A., Erickson M.A. The s1 protein of sars-cov-2 crosses the blood-brain barrier in mice. Nat. Neurosci. 2021;24:368&#x2013;378. doi: 10.1038/s41593-020-00771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Saniasiaya J. Hearing loss in sars-cov-2: What do we know? Ear Nose Throat J. 2021;100:152S&#x2013;154S. doi: 10.1177/0145561320946902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0145561320946902</ArticleId><ArticleId IdType="pmc">PMC7412079</ArticleId><ArticleId IdType="pubmed">32755405</ArticleId></ArticleIdList></Reference><Reference><Citation>Samaranayake L.P., Fakhruddin K.S., Panduwawala C. Sudden onset, acute loss of taste and smell in coronavirus disease 2019 (Covid-19): A systematic review. Acta Odontol. Scand. 2020;78:467&#x2013;473. doi: 10.1080/00016357.2020.1787505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016357.2020.1787505</ArticleId><ArticleId IdType="pubmed">32762282</ArticleId></ArticleIdList></Reference><Reference><Citation>Almufarrij I., Uus K., Munro K.J. Does coronavirus affect the audio-vestibular system? A rapid systematic review. Int. J. Audiol. 2020;59:487&#x2013;491. doi: 10.1080/14992027.2020.1776406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14992027.2020.1776406</ArticleId><ArticleId IdType="pubmed">32530326</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi-Galougahi M., Naeini A.S., Raad N., Mikaniki N., Ghorbani J. Vertigo and hearing loss during the Covid-19 pandemic&#x2014;Is there an association? Acta Otorhinolaryngol. Ital. 2020;40:463&#x2013;465. doi: 10.14639/0392-100X-N0820.</Citation><ArticleIdList><ArticleId IdType="doi">10.14639/0392-100X-N0820</ArticleId><ArticleId IdType="pmc">PMC7889249</ArticleId><ArticleId IdType="pubmed">32519994</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari M., Etemadifar M., Gharagozli K., Etemad K., Ashrafi F., Ashourizadeh H. Incidence of anxiety in epilepsy during coronavirus disease (Covid-19) pandemic. Epilepsy Behav. 2020;112:107442. doi: 10.1016/j.yebeh.2020.107442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yebeh.2020.107442</ArticleId><ArticleId IdType="pmc">PMC7494452</ArticleId><ArticleId IdType="pubmed">32949966</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti G., Giovannini G., Marudi A., Bedin R., Melegari A., Simone A.M., Santangelo M., Pignatti A., Bertellini E., Trenti T., et al. Anti-nmda receptor encephalitis presenting as new onset refractory status epilepticus in Covid-19. Seizure. 2020;81:18&#x2013;20. doi: 10.1016/j.seizure.2020.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2020.07.006</ArticleId><ArticleId IdType="pmc">PMC7362825</ArticleId><ArticleId IdType="pubmed">32688169</ArticleId></ArticleIdList></Reference><Reference><Citation>Sripadma P.V., Rai A., Wadhwa C. Postpartum atypical posterior reversible encephalopathy syndrome in a Covid-19 patient&#x2014;An obstetric emergency. J. Stroke Cerebrovasc. Dis. 2020;29:105357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519712</ArticleId><ArticleId IdType="pubmed">33039765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.W., Yusof Khan A.H.K., Ching S.M., Chia P.K., Loh W.C., Abdul Rashid A.M., Baharin J., Inche Mat L.N., Wan Sulaiman W.A., Devaraj N.K., et al. Stroke and novel coronavirus infection in humans: A systematic review and meta-analysis. Front. Neurol. 2020;11:579070. doi: 10.3389/fneur.2020.579070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.579070</ArticleId><ArticleId IdType="pmc">PMC7573135</ArticleId><ArticleId IdType="pubmed">33123082</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu T.M., Goh C., Tan Y.K., Leow A.S., Pang Y.Z., Chien J., Shafi H., Chan B.P., Hui A., Koh J., et al. Cerebral venous thrombosis in patients with Covid-19 infection: A case series and systematic review. J. Stroke Cerebrovasc. Dis. 2020;29:105379. doi: 10.1016/j.jstrokecerebrovasdis.2020.105379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105379</ArticleId><ArticleId IdType="pmc">PMC7538072</ArticleId><ArticleId IdType="pubmed">33254369</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa M., Kuno T., Mikami T., Takagi H., Gronseth G. Clinical characteristics of stroke with Covid-19: A systematic review and meta-analysis. J. Stroke Cerebrovasc. Dis. 2020;29:105288. doi: 10.1016/j.jstrokecerebrovasdis.2020.105288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105288</ArticleId><ArticleId IdType="pmc">PMC7456266</ArticleId><ArticleId IdType="pubmed">32992199</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisullo G., Bellavia S., Scala I., Piano C., Morosetti R., Brunetti V., Calabresi P., Della Marca G. Stroke and covid19: Not only a large-vessel disease. J. Stroke Cerebrovasc. Dis. 2020;29:105074. doi: 10.1016/j.jstrokecerebrovasdis.2020.105074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105074</ArticleId><ArticleId IdType="pmc">PMC7303643</ArticleId><ArticleId IdType="pubmed">32912559</ArticleId></ArticleIdList></Reference><Reference><Citation>Dakay K., Cooper J., Bloomfield J., Overby P., Mayer S.A., Nuoman R., Sahni R., Gulko E., Kaur G., Santarelli J., et al. Cerebral venous sinus thrombosis in Covid-19 infection: A case series and review of the literature. J. Stroke Cerebrovasc. Dis. 2021;30:105434. doi: 10.1016/j.jstrokecerebrovasdis.2020.105434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.105434</ArticleId><ArticleId IdType="pmc">PMC7833244</ArticleId><ArticleId IdType="pubmed">33190109</ArticleId></ArticleIdList></Reference><Reference><Citation>Asif R., O&#x2019;Mahony M.S. Rare complication of Covid-19 presenting as isolated headache. BMJ Case Rep. 2020;13:e239275. doi: 10.1136/bcr-2020-239275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-239275</ArticleId><ArticleId IdType="pmc">PMC7597500</ArticleId><ArticleId IdType="pubmed">33122242</ArticleId></ArticleIdList></Reference><Reference><Citation>Paliogiannis P., Mangoni A.A., Dettori P., Nasrallah G.K., Pintus G., Zinellu A. D-dimer concentrations and Covid-19 severity: A systematic review and meta-analysis. Front. Public Health. 2020;8:432. doi: 10.3389/fpubh.2020.00432.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00432</ArticleId><ArticleId IdType="pmc">PMC7438945</ArticleId><ArticleId IdType="pubmed">32903841</ArticleId></ArticleIdList></Reference><Reference><Citation>Bareeqa S.B., Ahmed S.I., Samar S.S., Yasin W., Zehra S., Monese G.M., Gouthro R.V. Prevalence of depression, anxiety and stress in china during Covid-19 pandemic: A systematic review with meta-analysis. Int. J. Psychiatry Med. 2020 doi: 10.1177/0091217420978005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0091217420978005</ArticleId><ArticleId IdType="pubmed">33243029</ArticleId></ArticleIdList></Reference><Reference><Citation>Burhamah W., AlKhayyat A., Oroszlanyova M., AlKenane A., Almansouri A., Behbehani M., Karimi N., Jafar H., AlSuwaidan M. The psychological burden of the Covid-19 pandemic and associated lockdown measures: Experience from 4000 participants. J. Affect. Disord. 2020;277:977&#x2013;985. doi: 10.1016/j.jad.2020.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.09.014</ArticleId><ArticleId IdType="pmc">PMC7476447</ArticleId><ArticleId IdType="pubmed">33065842</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo M., Guo L., Yu M., Jiang W., Wang H. The psychological and mental impact of coronavirus disease 2019 (Covid-19) on medical staff and general public&#x2014;A systematic review and meta-analysis. Psychiatry Res. 2020;291:113190. doi: 10.1016/j.psychres.2020.113190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113190</ArticleId><ArticleId IdType="pmc">PMC7276119</ArticleId><ArticleId IdType="pubmed">32563745</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva D.F.O., Cobucci R.N., Soares-Rachetti V.P., Lima S., Andrade F.B. Prevalence of anxiety among health professionals in times of Covid-19: A systematic review with meta-analysis. Cien Saude Colet. 2021;26:693&#x2013;710. doi: 10.1590/1413-81232021262.38732020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1413-81232021262.38732020</ArticleId><ArticleId IdType="pubmed">33605344</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844&#x2013;847. doi: 10.1111/jth.14768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14768</ArticleId><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J. The versatile heparin in Covid-19. J. Thromb. Haemost. 2020;18:1020&#x2013;1022. doi: 10.1111/jth.14821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14821</ArticleId><ArticleId IdType="pmc">PMC9906146</ArticleId><ArticleId IdType="pubmed">32239799</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinayagam S., Sattu K. Sars-cov-2 and coagulation disorders in different organs. Life Sci. 2020;260:118431. doi: 10.1016/j.lfs.2020.118431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.118431</ArticleId><ArticleId IdType="pmc">PMC7490584</ArticleId><ArticleId IdType="pubmed">32946915</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T., Connors J.M., Levy J.H. The coagulopathy, endotheliopathy, and vasculitis of Covid-19. Inflamm. Res. 2020;69:1181&#x2013;1189. doi: 10.1007/s00011-020-01401-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01401-6</ArticleId><ArticleId IdType="pmc">PMC7486586</ArticleId><ArticleId IdType="pubmed">32918567</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernuccio F., Lombardo F.P., Cannella R., Panzuto F., Giambelluca D., Arzanauskaite M., Midiri M., Cabassa P. Thromboembolic complications of Covid-19: The combined effect of a pro-coagulant pattern and an endothelial thrombo-inflammatory syndrome. Clin. Radiol. 2020;75:804&#x2013;810. doi: 10.1016/j.crad.2020.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crad.2020.07.019</ArticleId><ArticleId IdType="pmc">PMC7402367</ArticleId><ArticleId IdType="pubmed">32829885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J., Bai J. Protective effects of heparin on endothelial cells in sepsis. Int. J. Clin. Exp. Med. 2015;8:5547&#x2013;5552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4484034</ArticleId><ArticleId IdType="pubmed">26131136</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Mu S., Li X., Liang Y., Wang L., Ma X. Unfractionated heparin alleviates sepsis-induced acute lung injury by protecting tight junctions. J. Surg. Res. 2019;238:175&#x2013;185. doi: 10.1016/j.jss.2019.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2019.01.020</ArticleId><ArticleId IdType="pubmed">30771687</ArticleId></ArticleIdList></Reference><Reference><Citation>Young E. The anti-inflammatory effects of heparin and related compounds. Thromb. Res. 2008;122:743&#x2013;752. doi: 10.1016/j.thromres.2006.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2006.10.026</ArticleId><ArticleId IdType="pubmed">17727922</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.P., Vlodavsky I. Heparin, heparan sulfate and heparanase in inflammatory reactions. Thromb. Haemost. 2009;102:823&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">19888515</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmon C.T. Targeting factor xa and thrombin: Impact on coagulation and beyond. Thromb. Haemost. 2014;111:625&#x2013;633. doi: 10.1160/TH13-09-0730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH13-09-0730</ArticleId><ArticleId IdType="pubmed">24336942</ArticleId></ArticleIdList></Reference><Reference><Citation>Poterucha T.J., Libby P., Goldhaber S.Z. More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Thromb. Haemost. 2017;117:437&#x2013;444. doi: 10.1160/TH16-08-0620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH16-08-0620</ArticleId><ArticleId IdType="pubmed">27975101</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi S., Moradi M., Khorshidahmad T., Motamedi M. Anti-inflammatory effects of heparin and its derivatives: A systematic review. Adv. Pharmacol. Sci. 2015;2015:507151. doi: 10.1155/2015/507151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/507151</ArticleId><ArticleId IdType="pmc">PMC4443644</ArticleId><ArticleId IdType="pubmed">26064103</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez M.M.L., Contreras M.A., Marin W., D&#x2019;Marco L. Statins in Covid-19: Is there any foundation? Clin. Investig. Arterioscler. 2020;32:278&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7330559</ArticleId><ArticleId IdType="pubmed">32718669</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Liu J., Lu M., Yang D., Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40:998&#x2013;1004. doi: 10.1111/liv.14435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14435</ArticleId><ArticleId IdType="pmc">PMC7228361</ArticleId><ArticleId IdType="pubmed">32170806</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman C.B., Preiss D., Tobert J.A., Jacobson T.A., Page R.L., 2nd, Goldstein L.B., Chin C., Tannock L.R., Miller M., Raghuveer G., et al. Statin safety and associated adverse events: A scientific statement from the american heart association. Arterioscler. Thromb. Vasc. Biol. 2019;39:e38&#x2013;e81. doi: 10.1161/ATV.0000000000000073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATV.0000000000000073</ArticleId><ArticleId IdType="pubmed">30580575</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A., Johnson K.W., Januzzi J.L., Russak A.J., Paranjpe I., Richter F., Zhao S., Somani S., Van Vleck T., Vaid A., et al. Prevalence and impact of myocardial injury in patients hospitalized with Covid-19 infection. J. Am. Coll. Cardiol. 2020;76:533&#x2013;546. doi: 10.1016/j.jacc.2020.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Yan L., Fei Y., Zhang C. Laboratory abnormalities and risk factors associated with in-hospital death in patients with severe Covid-19. J. Clin. Lab. Anal. 2020;34:e23467. doi: 10.1002/jcla.23467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23467</ArticleId><ArticleId IdType="pmc">PMC7595920</ArticleId><ArticleId IdType="pubmed">32656888</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavishi C., Bonow R.O., Trivedi V., Abbott J.D., Messerli F.H., Bhatt D.L. Special article&#x2014;Acute myocardial injury in patients hospitalized with Covid-19 infection: A review. Prog. Cardiovasc. Dis. 2020;63:682&#x2013;689. doi: 10.1016/j.pcad.2020.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2020.05.013</ArticleId><ArticleId IdType="pmc">PMC7274977</ArticleId><ArticleId IdType="pubmed">32512122</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>